Algorithms that can detect subtle changes in a person’s voice are emerging as a potential new diagnostic tool for Parkinson’s disease, according to researchers from Iraq and Australia.
Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological diseases – epilepsy, multiple sclerosis (MS), peripheral neuropathy, Alzheimer’s disease and Parkinson’s disease. This is according to research published online in Neurology®, the medical journal of the American Academy of Neurology.
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer’s, and Parkinson’s disease continues to rise, especially for MS drugs, according to a study published in the October 30, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
New research by Rutgers Health researchers highlights a complex relationship between bacteria in the digestive tract and brain health.
The Speech Accessibility Project is now recruiting Canadian adults with Parkinson’s disease, cerebral palsy, amyotrophic lateral sclerosis, Down syndrome and those who have had a stroke.
McMaster University researchers have discovered a previously unknown cell-protecting function of a protein, which could open new avenues for treating age-related diseases and lead to healthier aging overall.
Biochemist David Baker — just announced as a recipient of the Nobel Prize for Chemistry — turned to the High Flux Isotope Reactor (HFIR) at Oak Ridge National Laboratory for information he couldn’t get anywhere else. HFIR is the strongest reactor-based neutron source in the United States.
Participants from the Cedars-Sinai Accelerator’s 10th class are set to showcase their leading-edge healthcare solutions during Demo Day at HLTH 2024 on Tuesday, Oct. 22, from 2:30 p.m. to 4 p.m. at The Venetian Expo Center in Las Vegas, Nevada.
At a glance: Study in mice reveals rapid release of dopamine is not needed for initiating movement but is important for activities related to reward-seeking and motivation. The findings help explain why the widely used Parkinson’s drug levodopa improves movement-related symptoms but often fails to ameliorate some cognitive ones. The work may inform the development of new therapies that restore both slow and fast dopamine action to treat multiple symptoms.
Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Symptoms can include hallucinations, movement disorders, cognitive issues, sleep problems and depression.
خرف أجسام ليوي هو مرض تنكسي عصبي متفاقم يشترك في بعض سماته مع داء باركينسون و داء الزهايمر، ولكنه قد يكون أكثر صعوبة في التشخيص. يمكن أن تشمل الأعراض الهلوسات واضطرابات الحركة ومشاكل في الإدراك واضطرابات النوم والاكتئاب.
A demência por corpos de Lewy (DCL) é uma doença neurodegenerativa progressiva que compartilha características tanto da doença de Parkinson quanto da doença de Alzheimer, mas que pode ser mais difícil de ser diagnosticada. Os sintomas podem incluir alucinações, distúrbios do movimento, problemas cognitivos, problemas de sono e depressão.
La demencia con cuerpos de Lewy (DCL) es una enfermedad neurodegenerativa progresiva que comparte características tanto de la enfermedad de Parkinson cuanto de la enfermedad de Alzheimer, pero que puede ser más difícil de diagnosticar. Los síntomas pueden incluir alucinaciones, trastornos del movimiento, problemas cognitivos, problemas para dormir y depresión.
A research team from the University of California, Irvine is the first to reveal that a molecule in the brain – ophthalmic acid – unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson’s and other movement diseases.
Binghamton University, State University of New York Psychology Professor Christopher R. Bishop is part of a collaborative research team that recently received a four-year grant from The Department of Defense to investigate the underlying cause of neuropsychiatric symptoms in Parkinson’s disease.
Announcement of contents of the October 2024 issue of Neurosurgical Focus: Video
Listening to people with Parkinson’s disease made an automatic speech recognizer 30% more accurate, according to initial findings from the Speech Accessibility Project. Speech recordings used in the study are freely available to organizations looking to improve their voice recognition devices.
Former NFL quarterback, Brett Favre announced this week he’s been diagnosed with Parkinson’s disease. He was diagnosed in January but announced it this week while testifying during a hearing on... ...
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
